New peer-reviewed, scientific study shows Vyleesi enhances sexual brain processing in premenopausal women with HSDD. Click here to learn more ›

February 2019

Palatin Technologies, Inc. Reports Second Fiscal Quarter 2019 Results and Provides Corporate Update

Press Releases / By

Teleconference and Webcast to be held on February 12, 2019 CRANBURY, N.J., Feb. 12, 2019 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems for the treatment of diseases with significant unmet medical need and …

Palatin Technologies, Inc. Reports Second Fiscal Quarter 2019 Results and Provides Corporate Update Read More »

Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on February 12, 2019

Press Releases / By

CRANBURY, N.J., Feb. 6, 2019 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter fiscal year 2019 operating results on Tuesday, February 12, 2019 before the open of the U.S. financial markets. Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on February 12, …

Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on February 12, 2019 Read More »

Scroll to Top